Use of link-tsg6 for the treatment of osteoarthritic pain
AssigneeThe University of Manchester
InventorsAnthony Day, Caroline Milner
Life of this patent
Estimating the term…
Abstract
This invention relates to the treatment of osteoarthritic pain, or pain associated with osteoarthritis, and particularly for LINK_TSG6 polypeptide for use in the treatment of osteoarthritic pain. Osteoarthritis is caused by the deterioration of cartilage in joints and is characterised by pain and a loss of mobility in the affected joints. Osteoarthritic pain results from multiple factors including bone marrow lesions, sub-articular bone attrition, synovitis, effusion and innervation of usually insensitive tissues. LINK_TSG6 is a short recombinant peptide comprising the LINK module of human TSG-6.
Claims14
A method of treating osteoarthritic pain comprising administering LINK_TSG6 to a patient in need thereof.
A composition comprising LINK_TSG6, wherein the composition is formulated for subcutaneous administration.
A composition comprising LINK_TSG6, wherein the composition is formulated for intra-articular administration.
(canceled)
(canceled)
Dependencies are inferred from the claim text.